Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 November 2020 | Story Thabo Kessah | Photo Thabo Kessah
Prof Pearl Sithole acknowledged the role played by the Afromontane Research Unit in securing mountain-to-mountain research funding from the US Embassy and Consulates in SA.

“This launch is an opportunity to reflect on the strategic significance of the partnership between our two universities and the long-standing relationship that academics at the two institutions have enjoyed.” 

These were the words of appreciation from the University of the Free State Vice-Rector: Research, Innovation and Internationalisation, Prof Corli Witthuhn, during the virtual launch of the Mountain-to-Mountain collaboration project between the University of the Free State and the Appalachian State University in the United States held on 10 November 2020. The R8 million project is funded by the US Embassy and Consulates in South Africa and will run over two academic years.

Prof Witthuhn also stated that the project would further strengthen the UFS strategy for internationalisation. “This collaboration has grown organically in the last decade to become one of the UFS flagships in international collaborations. With the support of this grant from the US Embassy and Consulates in South Africa, this long-standing and sustainable collaboration will be further strengthened,” she added.

New master’s programmes

In providing context to the Qwaqwa Campus’ research footprint, Campus Vice-Principal: Academic and Research, Prof Pearl Sithole, acknowledged the role played by the Afromontane Research Unit (ARU) under the leadership of its Director, Dr Ralph Clark, as well as all the faculties.

“In the Humanities, a lot is coming regarding the socio-ecosystems of the mountains. And in Education and Economic and Management Sciences, the scholarship of teaching and learning is promoted through blended skills, especially during this time of the pandemic. In the Natural and Agricultural Sciences, climate monitoring is one of the projects that has brought vibrancy to our campus,” she said.

Appalachian State University’s Associate Vice-Chancellor for International Education and Development, Prof Jesse Lutabingwa, mentioned that the collaboration would, among others, develop and offer a multi-disciplinary master’s degree in Mountain Studies on the Qwaqwa Campus, which will initially enrol seven to ten students. “In the subsequent years, we plan to increase this number to 15-20 students. We will also develop and offer a Community Development master’s degree with 10-12 students and up to 25 in subsequent years.”

Black women academics

Prof Lutabingwa, who is also the Project Director, revealed that doctoral students who are currently part of the University Staff Doctoral Project (USDP), will conduct at least three research projects focusing on social entrepreneurship, substance abuse, and rural transport monitoring in the Maloti-Drakensberg Mountains. “Also key to this collaboration is the leadership mentorship programme for black women academics who will at the end of the project produce three to five research papers,” Prof Lutabingwa added.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept